The Glyconeer®

Fully Automated Oligosaccharide Synthesizer, since 2013

GlycoUniverse GmbH & Co. KGaA (Potsdam, Germany) is an exclusive supplier of world's first automated oligosaccharide synthesizer Glyconeer®, dedicates to advance carbohydrate-based research.

Glyconeer
About Glyconeer®: It is the world's first commercial automated oligosaccharide synthesizer, produced under exclusive licensing terms with MIT (Patent: PCT/US2001/025859) since 2013 and Max-Planck-Institute (Patents: PCT/EP2020/080922; PCT/EP2020/080979; PCT/EP2020/080964) since 2022. Twenty Glyconeers were delivered to international research centers, universities and companies in Germany, Austria, Italy, Great Britain, Spain, the Netherlands, China, Taiwan, Canada, Israel, Saudi Arabia, the United States of America, India, Singapore.

Glyconeer® Network

A fast growing community

Features & Specifications

The all-new Glyconeer® Discover model pushes the limits of what's possible on Automated Glycan Assembly (AGA) technology.

4 Patents
100+ Monosaccharides
Up to 8 Solvents
Up to 16 Reagents
Temperature
Machine
UV-Flow Sensor
50 mins Cycle Duration
Pre-cooling Block
Reaction Vessel
Building block
Fraction Collector
About Glyconeer®: It is the world's first commercial automated oligosaccharide synthesizer, produced under exclusive licensing terms with MIT (Patent: PCT/US2001/025859) since 2013 and Max-Planck-Institute (Patents: PCT/EP2020/080922; PCT/EP2020/080979; PCT/EP2020/080964) since 2022. Twenty Glyconeers were delivered to international research centers, universities and companies in Germany, Austria, Italy, Great Britain, Spain, the Netherlands, China, Taiwan, Canada, Israel, Saudi Arabia, the United States of America, India, Singapore.

Automated Glycan Assembly (AGA)

Take a closer look at the technology behind the Glyconeer®

AGA Technology

Application Highlights

Find a glycan structure. Glyconeer® makes it.

Application Reviews
Glycan Arrays
Isotopic Labelling

Glycan Standards

Highest grade and purity Ultra-sensitive experiments (e.g. IM-MS, IRMPD)

Ref: https://www.nature.com/articles/nature15388

Enzymatic Assays
Chemoenzymatic substrates
Glycoconjugates
New Biomaterials